
Professor Bernhard Küster, keynote speaker at EACR 2026, talks about his scientific journey from chemistry to chemical proteomics and precision medicine. He reflects on how an interdisciplinary mindset - combining chemistry, biology, and computational science - has shaped his approach to understanding how drugs act on proteins and how this knowledge can inform personalised cancer treatments. He also shares practical advice for early-career researchers on how to embrace interdisciplinarity in their work. Bernhard discusses his team’s pioneering work developing technologies such as Prosit, Decrypt-E and Decrypt-M, and highlights how artificial intelligence is accelerating discoveries in proteomics. He also underscores the vital role of the clinical community in providing well-annotated tumour samples - an essential foundation for meaningful AI-driven cancer research. 🔗 Access transcripts for all our episodes at magazine.eacr.org/podcast
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

How Nerves Shape Cancer: From Energy Rewiring to Metastasis

Patients Shaping Cancer Research

From Bedside to Bench: Lessons from three award-winning scientists

A lifelong quest to understand cancer and cellular plasticity: Prof Xin Lu’s research journey following P53
Free AI-powered recaps of The Cancer Researcher Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.